| Date Filed | Type | Description |
| 10/04/2023 |
4
| Davis Jennifer L. (CEO - Health Care) has filed a Form 4 on PROCTER & GAMBLE Co|
Txns:
| Granted 52,251 options to buy
@ $145.19, valued at
$7.6M
|
|
| 08/21/2023 |
4
| Davis Jennifer L. (CEO - Health Care) has filed a Form 4 on PROCTER & GAMBLE Co|
Txns:
| Sold 5,761 shares
@ $152.8461, valued at
$880.5k
|
|
| 08/18/2023 |
4
| Davis Jennifer L. (CEO - Health Care) has filed a Form 4 on PROCTER & GAMBLE Co|
Txns:
| Granted 12,843 shares
@ $0
Granted 12 restricted stock units
@ $0 |
|
| 08/17/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 08/04/2023 |
4
| Davis Jennifer L. (CEO - Health Care) has filed a Form 4 on PROCTER & GAMBLE Co|
Txns:
| Granted 12 restricted stock units
@ $0
Granted 109 preferred shares
@ $0
Granted 791 restricted stock units
@ $0 |
|
| 04/25/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/21/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 12/09/2022 |
4
| Davis Jennifer L. (CEO - Health Care) has filed a Form 4 on PROCTER & GAMBLE Co|
Txns:
| Exercised 37 shares
@ $149.18, valued at
$5.6k
Paid exercise price by delivering 37 shares
@ $149.18, valued at
$5.6k
Granted 13 restricted stock units
@ $0
Exercised 37 restricted stock units
@ $0 |
|
| 10/04/2022 |
4
| Davis Jennifer L. (CEO - Health Care) has filed a Form 4 on PROCTER & GAMBLE Co|
Txns:
| Granted 6,746 shares
@ $0
Granted 29,198 options to buy
@ $128.51, valued at
$3.8M
|
|
| 08/24/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/18/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/05/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/04/2022 |
3
| Davis Jennifer L. (CEO - Health Care) has filed a Form 3 on PROCTER & GAMBLE Co |